ArticleChemistry & biodiversity2026
Phytochemical Composition, In Vitro Antioxidant, Antibacterial, and Antibiofilm Activities of Thymus vulgaris Essential Oil From Tiaret, Algeria.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study aimed to evaluate the antibacterial, antibiofilm, and anti-virulence potential of Thymus vulgaris essential oil (TvEO), along with its antioxidant activity. GC-MS analysis identified 32 constituents, representing 97.83% of the total composition, with thymol as the predominant compound, accounting for more than 70%. The TvEO exhibited notable bactericidal activity against the tested bacterial strains, with minimum inhibitory concentration (MIC) values ranging from 0.0078% to 0.03125% (v/v). Staphylococcus aureus (S. aureus) showed the highest sensitivity, with the lowest MIC value (0.0078%). Furthermore, TvEO reduced MRSA biofilm formation by more than 90% at the highest tested concentration (1% v/v) and decreased established biofilms by approximately 60%. Molecular docking analysis indicated that certain components of TvEO may interact with CrtM and SarA proteins, which are involved in S. aureus biofilm formation and virulence factor production. Moreover, TvEO demonstrated significant antioxidant potential according to DPPH and ABTS assays, with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.